Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrazoloacridine Followed by Radiation in Newly Diagnosed Glioblastoma
NCT00006355Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- May 2000
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyrazoloacridine in glioblastoma multiforme (GBM), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started May 2000; status: completed.
02
Drugs
pyrazoloacridine
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00006355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006355.